Ionis announces positive data from GSK's Phase 2b clinical study of bepirovirsen

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that GSK presented positive end of study data from the Phase 2b B-Clear study of...

Related Keywords

Washington ,District Of Columbia ,United States ,Richards Geary , ,Exchange Commission ,Prnewswire Ionis Pharmaceuticals Inc ,Twitter ,World Health Organization ,Ionis Pharmaceuticals Inc ,Ionis Pharmaceuticals ,Nasdaq ,American Association ,Liver Disease ,B Clear Phase ,Thenew England Journal ,Lower Limit ,Nc ,